Bengaluru, December 28, 2016: Bengaluru-based Cytecare Cancer Hospitals announced the appointment of Dr.HariMenon as Senior Consultant – Haemato-Oncology. Dr. Menon has been in the field of medical oncology for nearly 2 decades, where he has been associated with reputed hospitals like the Tata Memorial Cancer Centre, Mumbai. His special focus liesin the specialized field of hematological malignancies, which caters to both leukaemia (blood cancers) and lymphomas (malignancies associated with the lymphoid reticular system). His key areas include Acute and Chronic Leukaemia, Lymphomas, Central Nervous System Tumours and Stem Cell Therapy.
Speaking about his appointment, Dr. HariMenon said, “Cytecare is focused on improvingthe quality of cancer care in India and is committed to international standards of research in the field. This is a great opportunity for me to leverage my two decades of experience to push Cytecare’sendeavour in creating a more patient-centric cancer care system.”
Dr. Menon has been a member of the ICMR (Indian Council of Medical Research) task force for formulating guidelines in haematological malignancies and was the recipient of the ACORD (Australia & Asia Pacific Clinical Oncology Research Development) and INDOX (India Oxford clinical research) training. Additionally, he is also a national faculty for ACORD and CREDO in India which are bodies involved in training researchers and oncologists in the field of clinical research.
Commenting on the appointment, Mr. Suresh Ramu, CEO & Co Founder, Cytecare Hospitals, said “Dr. Menon comes with immense expertise and experience in the field of haemato-oncology and we are happy to have him lead a team of doctorsat Cytecare. Recognizing the growing need for quality cancer care in India, we aim to create an institution based on clinical excellence, global best practices and research facilities, delivering superior clinical outcomes while focusing on individual patient needs.”
Prior to joining Cytecare, Dr. Menon had worked at the Tata Memorial Cancer Centre, Mumbai, as a consultant and Professor of Medical Oncology for the past 12 years. During his stint at Tata, he was featured consistently among the best oncologists in the country, and was nominated twice for being among Mumbai’s Top Docs in peer-nominated surveys.
Dr. Menon has been credited with over 50 publications, and numerous presentations and book chapters. He is member of the American society of hematology and the European hematology association. Dr. Menon is a Reviewer for Indian and International peer-reviewed oncology journals, and has been an invited member of the advisory board for drug development by several multi-national pharmaceutical companies. He is also associated with cancer patient advocacy and support groups, and with agencies striving to make cancer care widely available to patients.
Corporate Comm India(CCI Newswire)
